4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780662-26-000002
Chief Financial Officer sold 2,145 shares at $18.46 ($39,597)
- Chief Financial Officer acquired 2,145 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,145 | $12.14 | $26,040 | 218,782 | D |
| 2026-02-04 | Sale : show line 2 in the form 10b5-1 | −2,145 | $18.46 | $39,597 | 216,637 | D |
| Open-market sales · 2,145 sh · avg $18.46 · $39,597 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-04 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −2,145 | 2,146 | D |
Loading xslF345X05/primary_doc.xml…